Philippe Van Wilder

The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data

Irina Odnoletkova, Gerhard Kindle, Isabella Quinti et al. · Orphanet Journal of Rare Diseases · 2018 · 179 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Belgian Methodological Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Requests

Irina Cleemput, Philippe Van Wilder, Michel Huybrechts et al. · Value in Health · 2008 · 37 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +17

Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective

Lieven Annemans, Philippe Beutels, David E. Bloom et al. · Value in Health · 2020 · 34 citations · Full text

Social Sciences, Economics, Health Policy +17

Advanced Therapy Medicinal Products and Exemptions to the Regulation 1394/2007: How Confident Can We be? An Exploratory Analysis

Philippe Van Wilder · Frontiers in Pharmacology · 2012 · 33 citations · Full text

Pharmacy, Health Law, Regulatory Policy +14

Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis

Yannick Vandenplas, Steven Simoens, Philippe Van Wilder et al. · Frontiers in Pharmacology · 2021 · 29 citations · Full text

Pharmacy, Intellectual Property Law, Pharmaceutical Policy +17